Research Article
Clinical Efficacy of Bendamustine Plus Rituximab (BR) for B-cell Relevant Indolent Non-Hodgkin’s Lymphoma and Role of β2-MG in Predicting the Efficacy of BR Regimen: A Real-World Retrospective Study in China
Figure 6
Subgroup survival curves of the β2-MG expression change rate: (a) PFS of the change group (blue) and the change group (red); (b) OS of the change group and the change group.
(a) |
(b) |